These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18676683)

  • 21. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clopidogrel-statin interaction.
    Tantry US; Jeong YH; Gurbel PA
    Circ J; 2014; 78(3):592-4. PubMed ID: 24521731
    [No Abstract]   [Full Text] [Related]  

  • 23. The cost of new therapies in cardiovascular care. Time for hope or despair for developing countries.
    Omeish AF
    Saudi Med J; 2007 May; 28(5):675-82. PubMed ID: 17457431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of adverse clopidogrel-atorvastatin clinical interaction.
    Saw J; Topol EJ
    Am J Cardiol; 2004 Mar; 93(5):669; author reply 669-70. PubMed ID: 14996608
    [No Abstract]   [Full Text] [Related]  

  • 25. 'Muscle-sparing' statins: preclinical profiles and future clinical use.
    Pfefferkorn JA
    Curr Opin Investig Drugs; 2009 Mar; 10(3):245-52. PubMed ID: 19333882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atorvastatin-clopidogrel interaction.
    Martin PT; Denman R
    Circulation; 2003 Jun; 107(24):e223; author reply e223. PubMed ID: 12821599
    [No Abstract]   [Full Text] [Related]  

  • 27. The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project.
    Niu S; Zhao D; Zhu J; Liu J; Liu Q; Liu J; Wang W; Smith SC;
    Am Heart J; 2009 Apr; 157(4):709-15.e1. PubMed ID: 19332200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methodological issues of retrospective studies assessing health outcomes of potential clopidogrel-statin interaction.
    Liu Y; Unni E
    Int J Pharm Pract; 2014 Oct; 22(5):360-2. PubMed ID: 24397257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPI interactions with clopidogrel.
    Med Lett Drugs Ther; 2009 Jan; 51(1303):2-3. PubMed ID: 19122567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin therapy: not just used to lower cholesterol?
    Kronmann L; Hatfield C; Kronmann K
    Crit Care Nurs Q; 2007; 30(2):154-60. PubMed ID: 17356356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the use of statins compromise the effectiveness of platelet inhibition by clopidogrel?
    Ford I; Williams D
    Platelets; 2004 Jun; 15(4):201-5. PubMed ID: 15203710
    [No Abstract]   [Full Text] [Related]  

  • 32. Do the association of cytochrome P450 interacting drugs, influence clopidogrel efficacity?
    Tho A; Mihoubi A
    Am Heart J; 2009 Jul; 158(1):e7; author reply e9. PubMed ID: 19540383
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
    James S; Akerblom A; Cannon CP; Emanuelsson H; Husted S; Katus H; Skene A; Steg PG; Storey RF; Harrington R; Becker R; Wallentin L
    Am Heart J; 2009 Apr; 157(4):599-605. PubMed ID: 19332184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium-channel blockers reduce the antiplatelet effect of clopidogrel.
    Siller-Matula JM; Lang I; Christ G; Jilma B
    J Am Coll Cardiol; 2008 Nov; 52(19):1557-63. PubMed ID: 19007592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipophilic statins do not affect the antiplatelet potency of clopidogrel.
    Tselepis AD; Goudevenos JA
    Platelets; 2005; 16(3-4):225-6. PubMed ID: 16011971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.
    Thomas D; Giugliano RP
    Crit Pathw Cardiol; 2009 Mar; 8(1):12-9. PubMed ID: 19258833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients.
    Launay-Vacher V; Izzedine H; Deray G
    Int J Cardiol; 2005 May; 101(1):9-17. PubMed ID: 15860377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-atherosclerotic effect of atorvastatin and clopidogrel alone and in combination in rats.
    Srinivas M; Annapurna A; Reddy YN
    Indian J Exp Biol; 2008 Oct; 46(10):698-703. PubMed ID: 19024167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interaction between clopidogrel and statins?].
    Poulsen TS; Mickley H; Damkier P
    Ugeskr Laeger; 2004 Jun; 166(24):2370-1; author reply 2371. PubMed ID: 15281583
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug interaction between clopidogrel and proton pump inhibitors.
    Khalique SC; Cheng-Lai A
    Cardiol Rev; 2009; 17(4):198-200. PubMed ID: 19525682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.